scispace - formally typeset
Open Access

GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012

Reads0
Chats0
About
The article was published on 2013-01-01 and is currently open access. It has received 2533 citations till now.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Oxidative stress in prostate cancer patients: A systematic review of case control studies

TL;DR: Upregulated OS profiles and impairment of antioxidant defense systems may play a role in men with PCa, and robust clinical trials utilizing a personalized approach which monitors both OS and antioxidant markers during therapy are warranted.
Journal ArticleDOI

The need for palliative care in Ireland: A population-based estimate of palliative care using routine mortality data, inclusive of nonmalignant conditions

TL;DR: Future palliative care policy decisions in Ireland must consider the rapidly aging Irish population with the accompanying increase in deaths from cancer, dementia, and neurodegenerative disease and associated palliatives care need.
Journal ArticleDOI

Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil ® ): A Review of Its Use in the Prevention of Premalignant Anogenital Lesions, Cervical and Anal Cancers, and Genital Warts

TL;DR: The quadrivalent HPV vaccine offers an effective means to substantially reduce the burden of HPV-related anogenital disease in females and males, particularly cervical cancer and genital warts, and was usually predicted to be cost effective in girls and young women.
Journal ArticleDOI

Sustainability and affordability of cancer drugs: a novel pricing model

TL;DR: This work has developed an approach based upon the adoption of a novel model of price setting that is intended to alter the balance between social and economic entrepreneurship.
Journal ArticleDOI

Role of VEGF, CD105, and CD31 in the Prognosis of Colorectal Cancer Cases

TL;DR: CRC patients with high VEGF, CD105, and CD31 expression showed poor prognosis and the immunohistochemical markers could be used for stratification of patients into low-risk and high-risk groups.
Related Papers (5)